#SARS-CoV2
LightNews LightNews
chantzy.bsky.social
Now do repeat SARS-CoV2 infections...
November 2, 2026 at 12:39 PM
tuomasjmattila.eurosky.social
Se on #pandemiaPerjantai ja uudet @thlfi.bsky.social #SARS-CoV2 #jätevesi datat. Päivitetyt kaaviot, olkaa hyvät!
- syysepidemia etenee hissukseen
- määrät edelleen alhaisia
- näyttää viime vuoden toistolta, jolloin jäi matalalle
Graphs with Sars-CoV2 virus amounts in wastewater across Finnish cities. Graphs showing multiple years of SARS-CoV2 data in wastewater in multiple Finnish cities.
October 30, 2026 at 1:03 PM
mpoessel.de
Soweit ich erinnere war die Aussage, dass sich Sars Cov2 von der Wirkung her den anderen Coronaviren, die ja auch zirkulieren, annähert.
October 31, 2026 at 10:31 PM
tomkindlon.bsky.social
Effects of prolonged SARS-CoV2 spike protein exposure in long COVID and a mouse model of the disease

ajp.amjpathol.org/article/S000...

Screenshot from latest Science for ME weekly update

#LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome
Effects of prolonged SARS-CoV2 spike protein exposure in long COVID and a mouse model of the disease — Nuovo et al "1) the SARS-CoV2 spike glycoprotein is able to persist in endothelia for at least 1.5 months in the CNS microvasculature in mice and probably up to several years in humans; 2) the persistent endothelial cell injury syndrome along with the microvasculature pro-inflammatory milieu associated with the viral spike protein and complement pathway activation can induce a chronic microangiopathy with the thickened vessels exhibiting type I collagen deposition." Article | Thread
October 28, 2026 at 1:25 AM
volxfeind.bsky.social
Ich wünsche dem Virus alles Gute und viel Erfolg. Do your magic, SARS-CoV2. ✌️
October 26, 2026 at 9:31 PM
670rv.bsky.social
Hide evidence, plunder the rest of population, accumulate wealth and engage in global conflicts - by using race and religion - and have stalked climate science since 1980s, drove climate crisis and when decrease biological diversity brought on SARS CoV2 - against mitigations, vaccine and ignore LC!
October 29, 2026 at 9:55 PM
Does he still not understand that SARS-CoV2 will never go into "endemicity?"
October 28, 2026 at 7:55 PM
lulachthesimple.bsky.social
There's a truth trying to escape from that very catchy slogan.

It wasn't SARS-Cov2 that destroyed the economy, it was the neoliberal response to a pandemic (by trying to pretend that there was no pandemic and later putting patches on, to protect the rich & institutions).
#BuildBackBetter? My arse.
November 2, 2026 at 6:49 AM
670rv.bsky.social
@ryanhisner.bsky.social

Not sure if earlier vaccination is antibody mediated or help from memory from T or B cells!
long lasting plasma cells not induced by SARS CoV2 either by infection or vaccination
October 26, 2026 at 1:30 PM
arandrea.eurosky.social
De fet, la vacuna de mRNA contra el SARS-CoV2 acostuma a donar febre i aquesta ni tan sols és el virus sencer, és el mRNA que codifica per 1 proteïna. El sistema immunitari crea la resposta contra aquesta proteïna i és aquesta resposta (x alliberació d'interleucines) la que provoca la febre.
October 28, 2026 at 10:40 AM
davidepike.bsky.social
and a type of sterilizing vaccine for SARS CoV2, hopefully a nasal spray version that simplifies administration and cuts costs
October 24, 2026 at 2:52 PM
lilyl.bsky.social
Das wird in Deutschland ziemlich sicher niemand bekommen. Im Allgemeinen wird ja in Praxen nicht mal mehr auf SARS-Cov2 getestet, geschweige denn bei vorliegender Infektion irgendwie behandelt. Da wird doch niemand präventiv ein teures Chemotherapeutikum verordnen... Kostenpunkt über 3000 Euro.
October 25, 2026 at 8:35 AM
justjay789.bsky.social
Azvudine is an antiviral drug which acts as a reverse transcriptase inhibitor, used for COVID-19, in China

Ensitrelvir, brand name Xocova, is an antiviral drug used as a treatment for COVID-19, in Japan

Would be good to know about these, but we really need multidrug cocktails against SARS CoV2
October 30, 2026 at 2:39 AM
didaclopezmartinez.bsky.social
Incidència setmanal (43/2026) d'infeccions respiratòries agudes a Catalunya per cada 100.000 hab.:
- 576 casos. Virus detectats: rinovirus (35,1%) SARS-COV2 (16,2%), coronavirus endèmics (10%).
sivic.salut.gencat.cat
sivic.salut.gencat.cat
October 27, 2026 at 4:41 PM
michaelkinch.bsky.social
This is a good reminder that “population immunity” is a patchwork of exposure histories. Few children were vaccinated early on so they were the first cohort, whose immunity was (presumably) shaped mostly by Omicron. Such findings reinforce the complexity of the ever-moving target that is SARS-CoV2.
October 27, 2026 at 12:55 PM
emha.bsky.social
Sehr interessant, wo SARS-CoV2 überall eingreift. Danke für den Hinweis. 🫱🏻‍🫲🏼
October 26, 2026 at 9:31 AM
yvonneluijkx.bsky.social
Het is een grote complottheorieën show. Een advocaat die denkt dat Sars-Cov2 is gecreeerd is door Bill Gates zodat hij een biowapen ( lees de vaccins) kon inzettwn om miljoenen mensen te doden.
October 25, 2026 at 10:49 PM
s4me.info
Effects of prolonged SARS-CoV2 spike protein exposure in long COVID and a mouse model of the disease — Nuovo et al

#MECFS
Article Link
ajp.amjpathol.org
October 26, 2026 at 6:37 PM
therealbrian.bsky.social
It's also the genomics - for HIV, SARS-CoV2, MERS, and tons of other viruses. The ability to identify, share information about, and protect people from previously unknown pathogens is unreal.
October 23, 2026 at 11:00 PM
janhartmann.bsky.social
Von wegen OAS ("Antigenerbsünde"). Neue Studie von
@jbloomlab.bsky.social zeigt, dass SARS-CoV2 evolutionär Fähigkeit erlangt hat Rekrutierung naiver B-Zellen zu behindern. Dies ist intrinsische Eigenschaft von Omikron-Epitopen u. unabhängig von früheren Antigenkontakten
bsky.app/profile/jblo...
jbloomlab.bsky.social Bloom lab @jbloomlab.bsky.social · 12d
In new study, we show that SARS-CoV-2 has evolved decreased inherent antigenicity in humans, as quantified by a ~3-fold decrease in the number of naïve human B cells that can bind the spike RBD.

doi.org/10.64898/202...
doi.org
October 23, 2026 at 5:01 AM
davidepike.bsky.social
The notion that "herd immunity" applies to the SARS-CoV2 virus seems to be the myth it always was. The same seems to true for the idea of "immunity debt". Wishful thinking implemented as the basis for public health policy will always end up facing reality eventually.
October 24, 2026 at 2:50 PM
atranscendedman.bsky.social
Weill Cornell researchers studied 8 Long COVID patients and found persistent SARS-CoV-2 spike protein in small blood vessels, alongside inflammation and collagen buildup that may restrict blood flow, even years after infection.

ajp.amjpathol.org/article/S000...
Effects of prolonged SARS-CoV2 spike protein exposure in long COVID and a mouse model of the disease
We addressed the question: can the SARS-CoV2 spike protein persist in ACE2+ endothelia in the CNS/other sites and induce a prolonged microvasculature injury syndrome? People who died from COVID-19, wi...
ajp.amjpathol.org
October 21, 2026 at 12:21 PM
sascha-kersken.de
Herbert sagt auch dann tapfer weiter "Ach was, früher war es auch schon heiß!"
Vgl. Leute, die noch auf dem Sterbebett unter der Sauerstoffmaske die Existenz des SARS-CoV2-Virus geleugnet haben.
October 22, 2026 at 5:35 AM
coolpix-jpg.bsky.social
Not to preclude B̷i̴d̶e̵n̸ and co.'s inauguration of public health's wholesale liquidation / normalization of permissive anti-social behavior with S̴A̴R̵S̶-̸C̸O̶V̸2̴ transmission and harm, but these guys really are the horsemen of the post-public-health-apocalypse and deserve their wretched place in history.
October 23, 2026 at 5:41 PM
tomkindlon.bsky.social
From the US

Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids

www.cell.com/iscience/abs...

Screenshot from latest Science for ME weekly update

#LongCovid #PASC #PwLC #postcovid
Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids — Moss et al "we present data demonstrating that plasma 12-LO-derived metabolites were significantly increased during acute SARS-CoV2 infection in participants who went on to develop LC, and that this […] was independent of initial infection severity."
October 22, 2026 at 2:12 AM